Journal of the American Society of Hypertension
Volume 2, Issue 6 , Pages 439-447 , November 2008

Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium

  • Fernando S. Carneiro, MSc

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
    • Corresponding Author InformationCorresponding author: Fernando S. Carneiro, MSc, Medical College of Georgia, Department of Physiology, 1120 15th Street, CA-3141, Augusta, Georgia 30912. Tel: 706-721-0784; fax: 706-721-7299
    • ,
  • Zidonia N. Carneiro

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • ,
  • Fernanda R.C. Giachini, MSc

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
    • ,
  • Victor V. Lima, BSc

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • ,
  • Edson F. Nogueira, MD

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • ,
  • William E. Rainey, PhD

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • ,
  • Rita C. Tostes, PhD

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA
    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
    • ,
  • R. Clinton Webb, PhD

      Affiliations

    • Medical College of Georgia, Department of Physiology, Augusta, Georgia, USA

Received 5 March 2008 ,Accepted 8 July 2008.

References 

  1. Andersson KE. Pharmacology of penile erection. Pharmacol Rev. 2001;53:417–450
  2. Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol. 2003;170:S6–S13; discussion S13–4
  3. Leite R, Giachini FR, Carneiro FS, et al. Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer?. Recent Patents Cardiovasc Drug Discov. 2007;2:119–132
  4. Granchi S, Vannelli GB, Vignozzi L, et al. Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. Mol Hum Reprod. 2002;8:1053–1064
  5. Saenz de Tejada I, Carson MP, de las Morenas A, et al. Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum. Am J Physiol. 1991;261:H1078–H1085
  6. Holmquist F, Kirkeby HJ, Larsson B, et al. Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit. J Pharmacol Exp Ther. 1992;261:795–802
  7. Sullivan ME, Dashwood MR, Thompson CS, Muddle JR, Mikhailidis DP, Morgan RJ. Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: potential relevance to the pathogenesis of erectile dysfunction. J Urol. 1997;158:1966–1972
  8. Khan MA, Thompson CS, Angelini GD, Morgan RJ, Mikhailidis DP, Jeremy JY. Prostaglandins and cyclic nucleotides in the urinary bladder of a rabbit model of partial bladder outlet obstruction. Prostaglandins Leukot Essent Fatty Acids. 1999;61:307–314
  9. Bell CR, Sullivan ME, Dashwood MR, Muddle JR, Morgan RJ. The density and distribution of endothelin 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum. Br J Urol. 1995;76:203–207
  10. Dai Y, Pollock DM, Lewis RL, Wingard CJ, Stopper VS, Mills TM. Receptor-specific influence of endothelin-1 in the erectile response of the rat. Am J Physiol Regul Integr Comp Physiol. 2000;279:R25–R30
  11. Parkkisenniemi UM, Klinge E. Functional characterization of endothelin receptors in the bovine retractor penis muscle and penile artery. Pharmacol Toxicol. 1996;79:73–79
  12. Ari G, Vardi Y, Hoffman A, Finberg JP. Possible role for endothelins in penile erection. Eur J Pharmacol. 1996;307:69–74
  13. Mills TM, Chitaley K, Wingard CJ, Lewis RW, Webb RC. Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J Appl Physiol. 2001;91:1269–1273
  14. Wingard CJ, Husain S, Williams J, James S. RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum. Am J Physiol Regul Integr Comp Physiol. 2003;285:R1145–R1152
  15. Schiffrin EL. Vascular endothelin in hypertension. Vascul Pharmacol. 2005;43:19–29
  16. Tostes RC, Muscara MN. Endothelin receptor antagonists: another potential alternative for cardiovascular diseases. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5:287–301
  17. Ames RS, Sarau HM, Chambers JK, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 1999;401:282–286
  18. Liu Q, Pong SS, Zeng Z, et al. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun. 1999;266:174–178
  19. Gendron G, Gobeil F, Bélanger S, et al. Urotensin II-induced hypotensive responses in Wistar-Kyoto (WKY) and spontaneously hypertensive (Shr) rats. Peptides. 2005;26:1468–1474
  20. Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E, Pacaud P, Loirand G. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res. 2001;88:1102–1104
  21. Bottrill FE, Douglas SA, Hiley CR, White R. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol. 2000;130:1865–1870
  22. Douglas SA, Sulpizio AC, Piercy V, et al. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol. 2000;131:1262–1274
  23. Meuleman EJ. Prevalence of erectile dysfunction: need for treatment?. Int J Impot Res. 2002;14:S22–S28
  24. Carneiro FS, Giachini FR, Lima VV, et al. Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db Mouse. J Sex Med. 2008;5:1156–1166
  25. Chitaley K, Webb RC, Dorrance AM, Mills TM. Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int J Impot Res. 2001;13:S16–S20
  26. Gardiner SM, March JE, Kemp PA, Bennett T. Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response. Br J Pharmacol. 2004;143:422–430
  27. Giachini FR, Callera GE, Carneiro FS, Tostes RC, Webb RC. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?. Expert Opin Ther Targets. 2008;12:327–339
  28. Holmquist F, Persson K, Garcia-Pascual A, Andersson KE. Phospholipase C activation by endothelin-1 and noradrenaline in isolated penile erectile tissue from rabbit. J Urol. 1992;147:1632–1635
  29. Italiano G, Calabrò A, Spini S, Ragazzi E, Pagano F. Functional response of cavernosal tissue to distension. Urol Res. 1998;26:39–44
  30. Kim NN, Dhir V, Azadzoi KM, Traish AM, Flaherty E, Goldstein I. Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction. J Androl. 2002;23:76–83
  31. Christ GJ, Lerner SE, Kim DC, Melman A. Endothelin-1 as a putative modulator of erectile dysfunction: I. Characteristics of contraction of isolated corporal tissue strips. J Urol. 1995;153:1998–2003
  32. Peng H, Carretero OA, Alfie ME, Masura JA, Rhaleb NE. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene. Hypertension. 2001;37:974–980
  33. Hartner A, Cordasic N, Klanke B, Veelken R, Hilgers KF. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice. Nephrol Dial Transplant. 2003;18:1999–2004
  34. Foord SM, Bonner TI, Neubig RR, et al. International Union of Pharmacology (XLVI. G protein-coupled receptor list). Pharmacol Rev. 2005;57:279–288
  35. Zou Y, Nagai R, Yamazaki T. Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. FEBS Lett. 2001;508:57–60
  36. Tamura K, Okazaki M, Tamura M, Isozumi K, Tasaki H, Nakashima Y. Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling. Life Sci. 2003;72:1049–1060

 This study was supported by Grants from the National Institutes of Health (HL71138 and HL74167), Bethesda, Maryland and Fundacao de Amparo a Pesquisa do Estado de São Paulo, FAPESP, Brazil.

PII: S1933-1711(08)00144-7

doi: 10.1016/j.jash.2008.07.001

Journal of the American Society of Hypertension
Volume 2, Issue 6 , Pages 439-447 , November 2008

Article Tools

* Image Usage & Resolution